Financial Data and Key Metrics Changes - The meeting discussed the approval of a special resolution for a plan of arrangement involving the company and other entities, which requires at least 66.67% of votes cast by shareholders [10][11] - The company confirmed that requisite approvals were obtained for the arrangement resolution, liquidation resolution, and liquidator resolution [19] Business Line Data and Key Metrics Changes - The meeting included a non-binding advisory resolution regarding compensation for named executive officers related to the arrangement, which was also approved by shareholders [19] Market Data and Key Metrics Changes - No specific market data or key metrics changes were discussed during the meeting Company Strategy and Development Direction and Industry Competition - The company is pursuing a business combination agreement with Zenotherapeutics Incorporated and Zeno Acquisition Incorporated, indicating a strategic move towards consolidation and potential growth [10][11] Management's Comments on Operating Environment and Future Outlook - Management did not provide specific comments on the operating environment or future outlook during this meeting Other Important Information - The meeting was conducted virtually, allowing security holders to participate and vote electronically [2][4] - Voting results will be posted on the company's SEDAR Plus profile after the meeting [19] Q&A Session All Questions and Answers Question: Are there any questions regarding the arrangement resolution? - No questions were submitted during the voting periods for the arrangement resolution [12][14][16][18]